vs
Encompass Health Corp(EHC)与RESIDEO TECHNOLOGIES, INC.(REZI)财务数据对比。点击上方公司名可切换其他公司
RESIDEO TECHNOLOGIES, INC.的季度营收约是Encompass Health Corp的1.2倍($1.9B vs $1.5B),Encompass Health Corp净利率更高(9.5% vs 7.2%,领先2.3%),Encompass Health Corp同比增速更快(9.9% vs 2.0%),RESIDEO TECHNOLOGIES, INC.自由现金流更多($262.0M vs $116.7M),过去两年RESIDEO TECHNOLOGIES, INC.的营收复合增速更高(12.9% vs 8.3%)
Encompass Health Corp前身为Amcare及HealthSouth,总部位于美国阿拉巴马州伯明翰,是美国规模最大的住院康复服务提供商,在39个州及波多黎各拥有173家住院康复医院,为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
Resideo Technologies是2018年从霍尼韦尔分拆成立的美国跨国企业,主营住宅场景的温控、空气质量调节、湿度控制及安防系统,业务覆盖美国及全球市场。公司下设产品、分销两大业务板块,生产销售温度照明控制、安防、水气监测等智能家居硬件及配套软件产品。
EHC vs REZI — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $1.5B | $1.9B |
| 净利润 | $146.1M | $136.0M |
| 毛利率 | — | 29.6% |
| 营业利润率 | 16.7% | 7.4% |
| 净利率 | 9.5% | 7.2% |
| 营收同比 | 9.9% | 2.0% |
| 净利润同比 | 20.8% | 491.3% |
| 每股收益(稀释后) | $1.43 | $0.99 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
| Q4 25 | $1.5B | $1.9B | ||
| Q3 25 | $1.5B | $1.9B | ||
| Q2 25 | $1.5B | $1.9B | ||
| Q1 25 | $1.5B | $1.8B | ||
| Q4 24 | $1.4B | $1.9B | ||
| Q3 24 | $1.4B | $1.8B | ||
| Q2 24 | $1.3B | $1.6B | ||
| Q1 24 | $1.3B | $1.5B |
| Q4 25 | $146.1M | $136.0M | ||
| Q3 25 | $126.5M | $156.0M | ||
| Q2 25 | $142.1M | $-825.0M | ||
| Q1 25 | $151.5M | $6.0M | ||
| Q4 24 | $120.9M | $23.0M | ||
| Q3 24 | $108.2M | $20.0M | ||
| Q2 24 | $114.1M | $30.0M | ||
| Q1 24 | $112.5M | $43.0M |
| Q4 25 | — | 29.6% | ||
| Q3 25 | — | 29.8% | ||
| Q2 25 | — | 29.3% | ||
| Q1 25 | — | 28.9% | ||
| Q4 24 | — | 28.5% | ||
| Q3 24 | — | 28.7% | ||
| Q2 24 | — | 28.1% | ||
| Q1 24 | — | 26.9% |
| Q4 25 | 16.7% | 7.4% | ||
| Q3 25 | 14.9% | 8.3% | ||
| Q2 25 | 16.2% | 9.1% | ||
| Q1 25 | 16.4% | 7.7% | ||
| Q4 24 | 14.3% | 7.8% | ||
| Q3 24 | 13.6% | 6.9% | ||
| Q2 24 | 14.3% | 7.7% | ||
| Q1 24 | 13.6% | 8.6% |
| Q4 25 | 9.5% | 7.2% | ||
| Q3 25 | 8.6% | 8.4% | ||
| Q2 25 | 9.7% | -42.5% | ||
| Q1 25 | 10.4% | 0.3% | ||
| Q4 24 | 8.6% | 1.2% | ||
| Q3 24 | 8.0% | 1.1% | ||
| Q2 24 | 8.8% | 1.9% | ||
| Q1 24 | 8.5% | 2.9% |
| Q4 25 | $1.43 | $0.99 | ||
| Q3 25 | $1.24 | $0.85 | ||
| Q2 25 | $1.39 | $-5.59 | ||
| Q1 25 | $1.48 | $-0.02 | ||
| Q4 24 | $1.18 | $0.06 | ||
| Q3 24 | $1.06 | $0.07 | ||
| Q2 24 | $1.12 | $0.19 | ||
| Q1 24 | $1.10 | $0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | $661.0M |
| 总债务越低越好 | $2.4B | $3.2B |
| 股东权益账面价值 | $2.4B | $2.9B |
| 总资产 | $7.1B | $8.4B |
| 负债/权益比越低杠杆越低 | 1.00× | 1.11× |
8季度趋势,按日历期对齐
| Q4 25 | $72.2M | $661.0M | ||
| Q3 25 | $48.7M | $345.0M | ||
| Q2 25 | $99.1M | $753.0M | ||
| Q1 25 | $95.8M | $577.0M | ||
| Q4 24 | $85.4M | $692.0M | ||
| Q3 24 | $147.8M | $531.0M | ||
| Q2 24 | $154.4M | $413.0M | ||
| Q1 24 | $134.4M | $603.0M |
| Q4 25 | $2.4B | $3.2B | ||
| Q3 25 | $2.4B | $3.2B | ||
| Q2 25 | $2.3B | $2.0B | ||
| Q1 25 | $2.3B | $2.0B | ||
| Q4 24 | $2.4B | $2.0B | ||
| Q3 24 | $2.3B | $2.0B | ||
| Q2 24 | $2.7B | $2.0B | ||
| Q1 24 | $2.7B | $1.4B |
| Q4 25 | $2.4B | $2.9B | ||
| Q3 25 | $2.4B | $2.8B | ||
| Q2 25 | $2.3B | $2.6B | ||
| Q1 25 | $2.2B | $3.3B | ||
| Q4 24 | $2.1B | $3.3B | ||
| Q3 24 | $2.0B | $3.4B | ||
| Q2 24 | $1.8B | $3.3B | ||
| Q1 24 | $1.7B | $2.8B |
| Q4 25 | $7.1B | $8.4B | ||
| Q3 25 | $6.9B | $8.2B | ||
| Q2 25 | $6.8B | $8.5B | ||
| Q1 25 | $6.6B | $8.1B | ||
| Q4 24 | $6.5B | $8.2B | ||
| Q3 24 | $6.5B | $8.1B | ||
| Q2 24 | $6.4B | $8.0B | ||
| Q1 24 | $6.2B | $6.5B |
| Q4 25 | 1.00× | 1.11× | ||
| Q3 25 | 1.01× | 1.17× | ||
| Q2 25 | 1.02× | 0.77× | ||
| Q1 25 | 1.08× | 0.60× | ||
| Q4 24 | 1.14× | 0.61× | ||
| Q3 24 | 1.20× | 0.60× | ||
| Q2 24 | 1.46× | 0.61× | ||
| Q1 24 | 1.54× | 0.51× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $346.0M | $299.0M |
| 自由现金流经营现金流 - 资本支出 | $116.7M | $262.0M |
| 自由现金流率自由现金流/营收 | 7.6% | 13.8% |
| 资本支出强度资本支出/营收 | 14.8% | 2.0% |
| 现金转化率经营现金流/净利润 | 2.37× | 2.20× |
| 过去12个月自由现金流最近4个季度 | $439.2M | $-1.3B |
8季度趋势,按日历期对齐
| Q4 25 | $346.0M | $299.0M | ||
| Q3 25 | $270.8M | $-1.6B | ||
| Q2 25 | $270.2M | $200.0M | ||
| Q1 25 | $288.6M | $-65.0M | ||
| Q4 24 | $278.8M | $203.0M | ||
| Q3 24 | $267.8M | $147.0M | ||
| Q2 24 | $217.4M | $92.0M | ||
| Q1 24 | $238.8M | $2.0M |
| Q4 25 | $116.7M | $262.0M | ||
| Q3 25 | $83.7M | $-1.6B | ||
| Q2 25 | $113.3M | $180.0M | ||
| Q1 25 | $125.5M | $-96.0M | ||
| Q4 24 | $80.1M | $181.0M | ||
| Q3 24 | $120.3M | $125.0M | ||
| Q2 24 | $60.5M | $77.0M | ||
| Q1 24 | $99.4M | $-19.0M |
| Q4 25 | 7.6% | 13.8% | ||
| Q3 25 | 5.7% | -85.8% | ||
| Q2 25 | 7.8% | 9.3% | ||
| Q1 25 | 8.6% | -5.4% | ||
| Q4 24 | 5.7% | 9.7% | ||
| Q3 24 | 8.9% | 6.8% | ||
| Q2 24 | 4.6% | 4.8% | ||
| Q1 24 | 7.6% | -1.3% |
| Q4 25 | 14.8% | 2.0% | ||
| Q3 25 | 12.7% | 1.5% | ||
| Q2 25 | 10.8% | 1.0% | ||
| Q1 25 | 11.2% | 1.8% | ||
| Q4 24 | 14.1% | 1.2% | ||
| Q3 24 | 10.9% | 1.2% | ||
| Q2 24 | 12.1% | 0.9% | ||
| Q1 24 | 10.6% | 1.4% |
| Q4 25 | 2.37× | 2.20× | ||
| Q3 25 | 2.14× | -10.07× | ||
| Q2 25 | 1.90× | — | ||
| Q1 25 | 1.90× | -10.83× | ||
| Q4 24 | 2.31× | 8.83× | ||
| Q3 24 | 2.48× | 7.35× | ||
| Q2 24 | 1.91× | 3.07× | ||
| Q1 24 | 2.12× | 0.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
REZI
| ADI Global Distribution Segment | $1.2B | 62% |
| Safety And Security | $257.0M | 14% |
| Air | $211.0M | 11% |
| Energy Service | $153.0M | 8% |
| Public Utilities Inventory Water | $91.0M | 5% |